pharmaphorum December 22, 2024
Phil Taylor

Proposed reforms to the regulations for pharmacy benefit managers (PBMs) were dropped from the US Congress’ end-of-year bill to provide funding to the federal government.

The eleventh-hour agreement on a budget – which will keep the government operational for three months – was signed into law by President Joe Biden yesterday having passed votes in the House of Representatives and Senate. Without a deal, millions of federal employees would have found themselves on unpaid leave or working without pay.

The final text saw a number of legislative proposals culled in order to get it over the line, including measures that would have introduced stricter controls over the PBM sector that had been agreed upon by Congress as well as other...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity
MSD opens $1bn plant for HPV vaccine in the US
AI Superintelligence Startup Promises New Drug Discoveries
STAT+: Roche partners with Zealand Pharma to push forward obesity drug
Trends Shaping Direct to Patient in Pharma: Q&A with Scott Snyder

Share This Article